v3.26.3
Segment Reporting - Schedule of Information on Geographical Regions (Details) - AUD ($)
 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2024
Schedule of Information on Geographical Regions [Line Items]      
Hyper-immune products revenue $ 7,713,601 $ 7,287,002 $ 4,902,865
Revenue from external customers 7,713,601 7,287,002 4,902,865
Australia [Member] | Travelan [Member]      
Schedule of Information on Geographical Regions [Line Items]      
Hyper-immune products revenue 5,672,502 5,201,385 3,702,876
Revenue from external customers 5,672,502 5,201,385 3,702,876
Australia [Member] | ProIBS [Member]      
Schedule of Information on Geographical Regions [Line Items]      
Hyper-immune products revenue 85,221    
Revenue from external customers 85,221    
Australia [Member] | Protectyn [Member]      
Schedule of Information on Geographical Regions [Line Items]      
Hyper-immune products revenue 21,799 48,575 43,487
Revenue from external customers 21,799 48,575 43,487
United States [Member] | Travelan [Member]      
Schedule of Information on Geographical Regions [Line Items]      
Hyper-immune products revenue 1,768,411 1,658,336 1,075,614
Revenue from external customers 1,768,411 1,658,336 1,075,614
Canada [Member] | Travelan [Member]      
Schedule of Information on Geographical Regions [Line Items]      
Hyper-immune products revenue 165,668 378,706 80,888
Revenue from external customers $ 165,668 $ 378,706 $ 80,888